|
|
|
SENSEX
|
|
-188.50
|
-0.25%
|
74482.78
|
|
|
NIFTY
|
|
-38.55
|
-0.17%
|
22604.85
|
|
|
Nasdaq
|
|
-325.26
|
-2.04%
|
15657.82
|
|
|
Nikkei 225
|
|
470.90
|
1.24%
|
38405.66
|
|
|
FTSE 100
|
|
-2.90
|
-0.04%
|
8144.10
|
|
|
|
|
|
|
|
|
YOU ARE ON
Equity
|
|
|
|
|
|
|
|
|
Industry : Pharmaceuticals & Drugs |
House : Cadila |
BSE Code |
532321
|
ISIN Demat |
INE010B01027
|
Book Value (Rs) |
143.63
|
|
NSE Code |
ZYDUSLIFE
|
Dividend Yield % |
0.63
|
Market Cap (Rs) |
959544.73
|
|
TTM PE(x) |
37.97
|
TTM EPS(Rs) |
25.11
|
Face Value(Rs.) |
1
|
|
|
|
|
|
|
Incorporation Year
|
15-05 1995
|
Registered Office
|
Zydus Corporate Park, Scheme No.63,Survey No. 536, Khoraj (Gandhinagar), Nr. Vaishnodevi Circle,Sarkhej - Gandhinagar Highway, Ahmedabad, Gujarat-382481 .
|
ISINNO
|
INE010B01027
|
Phone
|
079-71800000 / 48040000
|
E-mail
|
dhavalsoni@zyduscadila.com |
URL
|
www.zyduscadila.com |
Industry
|
Pharmaceuticals & Drugs
|
Chairman
|
Pankaj R Patel
|
Managing Director
|
Sharvil P Patel
|
Company Secretary
|
Dhaval N Soni
|
Listing
|
BSE,NSE,MCX
|
|
|
|
|
|
|
|
|
|
|
|